EUVIMEDEUVIMED entdecken
Crossref

TIGIT regulates CD8+T cell exhaustion via the PI3K/AKT-FOXO1-TOX axis in extrahepatic cholangiocarcinoma

Ruiheng Luo, Ling Li, Dehong Tan, Ping Zheng, Yu He, Qianfei Zuo, Tengqian Tang

Clinical Immunology · 2026-12 · 288 · 110780

DOI: 10.1016/j.clim.2026.110780 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Immunology, 2026-12. Verfasst von Ruiheng Luo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, First Affiliated Hospital, Army Medical University, Chongqing 400038, PR China. Die Arbeit nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extrahepatic cholangiocarcinoma (ECCA) is an aggressive malignancy with poor prognosis and few treatment options, partly due to CD8+T cell exhaustion in the tumor microenvironment. The role of TIGIT in driving this process remains mechanistically unclear. Using patient-derived immunocompetent cultures (iPDCs), we show that TIGIT blockade in ECCA reverses exhaustion by downregulating TOX and restoring TCF-1. In mouse CD8+ T cells, transcriptomic analysis identifies the PI3K/AKT-FOXO1 axis as a critical mediator. Mechanistically, TIGIT suppresses AKT phosphorylation, leading to FOXO1 nuclear translocation, where FOXO1 directly binds the TOX promoter and activates its transcription. Together, these findings establish the TIGIT-PI3K/AKT-FOXO1-TOX axis as a core pathway driving CD8+T cell exhaustion in ECCA, filling a key mechanistic gap and offering new therapeutic targets for immunotherapy.

Schlagwörter

Stichwörter der Autor:innen

Extrahepatic cholangiocarcinomaFOXO1T cell exhaustionTIGITTOX

Autor:innen und Institutionen

  • Department of Hepatobiliary Surgery, First Affiliated Hospital, Army Medical University, Chongqing 400038, PR China.
  • Department of Dermatology, First Affiliated Hospital, Army Medical University, Chongqing 400038, PR China.
  • Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Army Medical University, Chongqing 400038, PR China.
  • Department of Hepatobiliary Surgery, First Affiliated Hospital, Army Medical University, Chongqing 400038, PR China. Electronic address: tangtq1982@163.com.

Zitieren

APA

Luo, R., Li, L., Tan, D., Zheng, P., He, Y., Zuo, Q., & Tang, T. (2026). TIGIT regulates CD8+T cell exhaustion via the PI3K/AKT-FOXO1-TOX axis in extrahepatic cholangiocarcinoma. Clinical Immunology, 288, 110780. https://doi.org/10.1016/j.clim.2026.110780

Vancouver

Luo R, Li L, Tan D, Zheng P, He Y, Zuo Q, et al. TIGIT regulates CD8+T cell exhaustion via the PI3K/AKT-FOXO1-TOX axis in extrahepatic cholangiocarcinoma. Clinical Immunology. 2026;288:110780. doi:10.1016/j.clim.2026.110780

BibTeX
@article{Luo2026,
  author = {Luo, Ruiheng and Li, Ling and Tan, Dehong and Zheng, Ping and He, Yu and Zuo, Qianfei and Tang, Tengqian},
  title = {TIGIT regulates CD8+T cell exhaustion via the PI3K/AKT-FOXO1-TOX axis in extrahepatic cholangiocarcinoma},
  journal = {Clinical Immunology},
  year = {2026},
  volume = {288},
  pages = {110780},
  doi = {10.1016/j.clim.2026.110780}
}
Kostenlos starten →